In CLL, an interesting work of Witkowska et al. recently linked the expression levels of SMADs proteins with clinical evolution and shows that lower SMAD-4 protein levels correlate with progressive course of the disease [29]. The gene discussed is SMAD4; the disease is B-cell chronic lymphocytic leukemia.